Recently added articles from Blood Weekly:
Of mice and men: Stem cells and ethical uncertainties.
Nov 19, 2009 ... The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics (see also Johns Hopkins Medical ...
Lung tissue generated from human embryonic stem cells.
Nov 19, 2009 ... Scientists in Belgium have successfully differentiated human embryonic stem cells (hESC) into major cell types of lung epithelial tissue using a convenient air-liquid interface. The technique, published in BioMed Central's open access journal Respiratory Research, could provide an ...
New anemia data have been reported by scientists at University of Texas.
Nov 19, 2009 ... According to a study from the United States, "Receiving recurring blood transfusions as supportive therapy to treat chronic anemias, such as myelodysplastic syndromes, thalassemia, and sickle-cell disease, are at risk of iron accumulation. The clinical consequences of iron overload are ...
Experimental agent reduces breast cancer metastasis to bone.
Nov 19, 2009 ... Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer. In a study in mice, the team of researchers from Tufts University School of Medicine, the Sackler School of ...
Affymax and Takeda Announce Hematide™ Publication in the New England Journal of Medicine.
Nov 19, 2009 ... Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Global Research & Development Center, Inc., announced data from a Phase 2 clinical trial of Hematide™ showing that Hematide increased hemoglobin and reduced or eliminated the need for blood transfusion in most patients with ...